Supplyside East

Top takeaways from regulatory session at SupplySide East

GMP inspections return to pre-COVID levels, but that's still not enough, says ODSP Director

26-Apr-2024 By Danielle Masterson

The U.S. Food & Drug Administration's good manufacturing practice (GMP) inspections of dietary supplement facilities is back up to 500 per year, a return to pre-COVID levels, but those levels are still inadequate, says Dr. Cara Welch, FDA’s director...

Kratom in market and legislative limbo

23-Apr-2024 By Claudia Adrien

“From both a consumer standpoint and from an industry standpoint, it's very hard to know what you can and can't do [with kratom],” industry lawyer Rick Collins told attendees at SupplySide East 2024.

ODSP’s Welch: NDIN 'guidances are not enforceable'

22-Apr-2024 By Danielle Masterson

FDA’s director of the Office of Dietary Supplement Programs (ODSP), Cara Welch, PhD, stopped by SupplySide East to present an overview of the agency’s FY23 activities related to dietary supplements and FY24 plans as well as an update on the pending Human...

CRN’s Steve Mister on NDI enforcement: 'That needs to change'

18-Apr-2024 By Danielle Masterson

SupplySide East just wrapped up, and attendees were buzzing about a number of issues ranging from restrictive laws to NDI guidance to DSHEA. NutraIngredients-USA caught up with CRN’s President and CEO Steve Mister Wednesday in Secaucus, NJ to discuss...

CRN: NDI guidance is 'doable'

24-Apr-2023 By Danielle Masterson

NutraIngredients-USA caught up with CRN’s Steve Mister at SupplySide East to discuss new research, top priorities for the year and what they hope to see from FDA this year.